TRIM33 and uterine corpus endometrial carcinoma: Elevated expression of TRIM33 is significantly associated with worse survival for Uterine Corpus Endometrial Carcinoma (UCEC) patients and with better survival for COAD and KIRC patients (Figure 1C).